Lara Longpre

1.2k total citations
4 papers, 20 citations indexed

About

Lara Longpre is a scholar working on Genetics, Biotechnology and Molecular Biology. According to data from OpenAlex, Lara Longpre has authored 4 papers receiving a total of 20 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Biotechnology and 3 papers in Molecular Biology. Recurrent topics in Lara Longpre's work include Virus-based gene therapy research (4 papers), Cancer Research and Treatments (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Lara Longpre is often cited by papers focused on Virus-based gene therapy research (4 papers), Cancer Research and Treatments (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Lara Longpre collaborates with scholars based in United States, South Korea and France. Lara Longpre's co-authors include Mong Cho, Ung Bae Jeon, David H. Kirn, Chang Won Kim, Jun Woo Lee, Jeong Heo, Richard H. Patt, Caroline J. Breitbach, Tae-Ho Hwang and Ki Tae Yoon and has published in prestigious journals such as Journal of Clinical Oncology.

In The Last Decade

Lara Longpre

4 papers receiving 20 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lara Longpre United States 3 12 9 6 6 4 4 20
Lifang Huang China 2 26 2.2× 10 1.1× 4 0.7× 8 1.3× 13 3.3× 4 35
Rosa Adaeva France 3 11 0.9× 3 0.3× 9 1.5× 3 0.5× 1 0.3× 4 35
Ryan Moslin United States 2 7 0.6× 6 0.7× 7 1.2× 2 0.5× 3 23
Longcheng Wang United States 3 4 0.3× 7 0.8× 5 0.8× 4 1.0× 3 26
Xuehao Cui China 4 10 0.8× 4 0.4× 8 1.3× 4 1.0× 11 32
Ahmad Mustafa Shiri Germany 3 16 1.3× 3 0.3× 8 1.3× 5 0.8× 7 1.8× 5 35
Thomas Haaf Germany 2 8 0.7× 11 1.2× 15 2.5× 3 0.8× 2 26
Petra Reinstadler Italy 2 4 0.3× 10 1.1× 6 1.0× 3 0.8× 5 22
Katie Farmer Philippines 2 4 0.3× 8 0.9× 5 0.8× 3 0.8× 2 15
Orla Stewart United Kingdom 4 31 2.6× 9 1.0× 8 1.3× 4 1.0× 6 39

Countries citing papers authored by Lara Longpre

Since Specialization
Citations

This map shows the geographic impact of Lara Longpre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Longpre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Longpre more than expected).

Fields of papers citing papers by Lara Longpre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Longpre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Longpre. The network helps show where Lara Longpre may publish in the future.

Co-authorship network of co-authors of Lara Longpre

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Longpre. A scholar is included among the top collaborators of Lara Longpre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Longpre. Lara Longpre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Heo, Jeong, Caroline J. Breitbach, Mong Cho, et al.. (2013). Phase II trial of Pexa-Vec (pexastimogene devacirepvec; JX-594), an oncolytic and immunotherapeutic vaccinia virus, followed by sorafenib in patients with advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 31(15_suppl). 4122–4122. 9 indexed citations
2.
3.
Heo, Jeong, Caroline J. Breitbach, Mong Cho, et al.. (2012). A phase II trial of JX-594, a targeted multimechanistic oncolytic vaccinia virus, followed by sorafenib in patients with advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 30(15_suppl). e14566–e14566. 3 indexed citations
4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lifang Huang Breakdown of academic impact, for papers by Rosa Adaeva Breakdown of academic impact, for papers by Ryan Moslin Breakdown of academic impact, for papers by Longcheng Wang Breakdown of academic impact, for papers by Xuehao Cui Breakdown of academic impact, for papers by Ahmad Mustafa Shiri Breakdown of academic impact, for papers by Thomas Haaf Breakdown of academic impact, for papers by Petra Reinstadler Breakdown of academic impact, for papers by Katie Farmer Breakdown of academic impact, for papers by Orla Stewart
Rankless by CCL
2026